Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Arrhythmias

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 230 articles: HTML format

Single Articles

March 2023
1. CREA F
   Cardiovascular diseases in pregnancy, congenital heart disease, and arrhythmias: lessons from epidemiology.
   Eur Heart J. 2023;44:699-702.
   PubMed    
   
   
   
2. AL-KAISEY AM, Kalman JM
   Atrial arrhythmia recurrence post-catheter ablation: when perfect is the enemy of good.
   Eur Heart J. 2023;44:777-779.
   PubMed    
   
   
   February 2023
3. GRAMMATIKA PAVLIDOU N, Dobrev S, Beneke K, Reinhardt F, et al
   Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism.
   Eur Heart J. 2023 Feb 22:ehad086. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. LIU X, Luo H, Qin X
   Vanishing 'table tennis': a case of active left atrial thrombus.
   Eur Heart J. 2023;44:698.
   PubMed    
   
   
   
5. WOUTERS PC, van de Leur RR, Vessies MB, van Stipdonk AMW, et al
   Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy.
   Eur Heart J. 2023;44:680-692.
   PubMed     Abstract available
   
   
   
6. LAMBIASE PD, Sanders P, Crijns HJGM
   The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias.
   Eur Heart J. 2023;44:345-347.
   PubMed    
   
   
   January 2023
7. GAUDINO M, Di Franco A, Rong LQ, Piccini J, et al
   Postoperative atrial fibrillation: from mechanisms to treatment.
   Eur Heart J. 2023 Jan 31:ehad019. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. BUTCHER SC, Essayagh B, Steyerberg EW, Benfari G, et al
   Factors influencing post-surgical survival in degenerative mitral regurgitation.
   Eur Heart J. 2023 Jan 26:ehad004. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. 
   Corrigendum to: Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
   Eur Heart J. 2023 Jan 24:ehad045. doi: 10.1093.
   PubMed    
   
   
   
10. KANAMURA T, Hashimoto T, Shiose A, Tsutsui H, et al
    Thrombus associated with locked-in atrial fibrillation in recipient remnant left atrium after heart transplantation.
    Eur Heart J. 2023 Jan 20:ehad008. doi: 10.1093.
    PubMed    
    
    
    
11. NARDUCCI ML, Pedicino D
    A new defibrillation strategy for refractory ventricular fibrillation during out-of-hospital cardiac arrest: are two better than one?
    Eur Heart J. 2023 Jan 20:ehad002. doi: 10.1093.
    PubMed    
    
    
    
12. WALDMANN V, Barra S, Marijon E
    Ventricular arrhythmias and sudden cardiac death in heart failure with mildly reduced or preserved ejection fraction: knowledge gaps.
    Eur Heart J. 2023 Jan 20:ehad001. doi: 10.1093.
    PubMed    
    
    
    
13. CREA F
    Management of atrial fibrillation: role of population screening, biomarkers, and polygenic risk scores.
    Eur Heart J. 2023;44:167-170.
    PubMed    
    
    
    
14. CURTAIN JP, Adamson C, Kondo T, Butt J, et al
    Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
    Eur Heart J. 2023 Jan 12:ehac801. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. ACHA MR, Glikson M
    Type 2 diabetes mellitus association with atrioventricular block.
    Eur Heart J. 2023 Jan 7:ehac755. doi: 10.1093.
    PubMed    
    
    
    December 2022
16. LIUZZO G, Patrono C
    Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation.
    Eur Heart J. 2022 Dec 17:ehac721. doi: 10.1093.
    PubMed    
    
    
    
17. MATUSIK PS, Matusik PT, Stein PK
    Heart rate variability and heart rate patterns measured from wearable and implanted devices in screening for atrial fibrillation: potential clinical and population-wide applications.
    Eur Heart J. 2022 Dec 17:ehac546. doi: 10.1093.
    PubMed    
    
    
    
18. CREA F
    Novel risk factors for atrial fibrillation, conduction disturbances, sudden coronary death, and device infection.
    Eur Heart J. 2022;43:4853-4857.
    PubMed    
    
    
    
19. LAZZERINI PE, Boutjdir M, Capecchi PL
    Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the 'dark side of the immune'.
    Eur Heart J. 2022;43:4920-4922.
    PubMed    
    
    
    
20. AKUKA A, Ben-Shabat N, Watad A, Tsur AM, et al
    Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances.
    Eur Heart J. 2022;43:4912-4919.
    PubMed     Abstract available
    
    
    
21. TFELT-HANSEN J, Winkel BG, de Riva M, Zeppenfeld K, et al
    The '10 commandments' for the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
    Eur Heart J. 2022 Dec 7:ehac699. doi: 10.1093.
    PubMed    
    
    
    
22. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. ANDREOTTI F, Geisler T, Collet JP, Gigante B, et al
    Acute, periprocedural and longterm antithrombotic therapy in older adults.
    Eur Heart J. 2022 Dec 7:ehac515. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. ANDRADE JG, Deyell MW, Macle L, Steinberg JS, et al
    Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study.
    Eur Heart J. 2022 Dec 2:ehac692. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. SPATZ ES, Herrin J
    Screening for atrial fibrillation to prevent stroke: increasing enthusiasm but outcomes still lag.
    Eur Heart J. 2022 Dec 2:ehac696. doi: 10.1093.
    PubMed    
    
    
    
26. OSMANCIK P, Widimsky P
    Left atrial appendage occluders-new hope for stroke prevention in high-risk patients.
    Eur Heart J. 2022;43:4669-4671.
    PubMed    
    
    
    November 2022
27. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. KU L, Chen Y, Ma X
    Pericardial-esophageal fistula caused by radiofrequency ablation for atrial fibrillation.
    Eur Heart J. 2022 Nov 22:ehac673. doi: 10.1093.
    PubMed    
    
    
    
29. SINNER MF, von Falkenhausen AS
    A specific new biomarker for atrial fibrillation and its sequelae?
    Eur Heart J. 2022 Nov 18. pii: 6833208. doi: 10.1093.
    PubMed    
    
    
    
30. GOLDENBERG L, Huang DT
    Subcutaneous implantable cardioverter defibrillator for the prevention of sudden cardiac death: ready for prime-time?
    Eur Heart J. 2022 Nov 16. pii: 6830653. doi: 10.1093.
    PubMed    
    
    
    
31. HIJAZI Z, Benz AP, Lindback J, Alexander JH, et al
    Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
    Eur Heart J. 2022 Nov 16. pii: 6830621. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. HARRINGTON J, Granger CB
    Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem.
    Eur Heart J. 2022 Nov 16. pii: 6830575. doi: 10.1093.
    PubMed    
    
    
    
33. HOLMSTROM L, Chugh SS
    How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
    Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
    PubMed    
    
    
    
34. LYTH J, Svennberg E, Bernfort L, Aronsson M, et al
    Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.
    Eur Heart J. 2022 Nov 9. pii: 6806218. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
35. GARCIA R, Marijon E, Karam N, Narayanan K, et al
    Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
    Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. MEYRE PB, Blum S, Hennings E, Aeschbacher S, et al
    Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
    Eur Heart J. 2022 Oct 26. pii: 6773770. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. GAWALKO M, Sanders P
    Drug abuse and risk of atrial fibrillation: a neglected association.
    Eur Heart J. 2022 Oct 26. pii: 6774408. doi: 10.1093.
    PubMed    
    
    
    
38. YANG Y, Xie L, Qian H, Cui K, et al
    Minimally invasive videoscope-assisted cardiac surgery for paroxysmal atrial tachycardia originating from right atrial appendage.
    Eur Heart J. 2022 Oct 26. pii: 6774389. doi: 10.1093.
    PubMed    
    
    
    
39. KAAB S, Holm H, Kirchhof P
    Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure.
    Eur Heart J. 2022 Oct 21. pii: 6767860. doi: 10.1093.
    PubMed    
    
    
    
40. CREA F
    New tools to predict and new therapeutic targets to treat life-threatening ventricular arrhythmias.
    Eur Heart J. 2022;43:3983-3986.
    PubMed    
    
    
    
41. BRIGNOLE M, Sutton R
    Left bundle branch area pacing in perspective.
    Eur Heart J. 2022;43:4174-4176.
    PubMed    
    
    
    
42. LINZ D, McIntyre WF
    Sinus rhythm: the sine qua non for rhythm control?
    Eur Heart J. 2022;43:4145-4147.
    PubMed    
    
    
    
43. JASTRZEBSKI M, Kielbasa G, Cano O, Curila K, et al
    Left bundle branch area pacing outcomes: the multicentre European MELOS study.
    Eur Heart J. 2022;43:4161-4173.
    PubMed     Abstract available
    
    
    
44. VANDEWIELE F, Pironet A, Jacobs G, Kecskes M, et al
    TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.
    Eur Heart J. 2022;43:4195-4207.
    PubMed     Abstract available
    
    
    
45. HEIJMAN J, Dobrev D
    Molecular determinants and therapeutic potential of focal ectopic activity: more than meets the Iti.
    Eur Heart J. 2022;43:4208-4210.
    PubMed    
    
    
    
46. TORBATI T, Shufelt C, Wei J, Noel Bairey Merz C, et al
    Premature menopause and cardiovascular disease: can we blame estrogen?
    Eur Heart J. 2022;43:4158-4160.
    PubMed    
    
    
    
47. MONDA E, Lioncino M, Limongelli G
    Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: the challenge of complex statistical modelling and its impact in clinical practice.
    Eur Heart J. 2022 Oct 20. pii: 6763998. doi: 10.1093.
    PubMed    
    
    
    
48. CADRIN-TOURIGNY J, Bosman LP, James CA
    Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: a practical approach to navigating the challenges of prediction models.
    Eur Heart J. 2022 Oct 20. pii: 6764102. doi: 10.1093.
    PubMed    
    
    
    
49. LIN AL, Nah G, Tang JJ, Vittinghoff E, et al
    Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation.
    Eur Heart J. 2022 Oct 18. pii: 6754793. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. LI J
    Long QT syndrome: long story short.
    Eur Heart J. 2022 Oct 18. pii: 6762505. doi: 10.1093.
    PubMed    
    
    
    
51. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    PubMed    
    
    
    September 2022
52. NABETA T, Kitai T, Naruse Y, Taniguchi T, et al
    Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
    Eur Heart J. 2022;43:3450-3459.
    PubMed     Abstract available
    
    
    
53. MA S, Jiang J
    Pulmonary vein stenosis stenting in a patient with persistent left superior vena cava after atrial fibrillation ablation.
    Eur Heart J. 2022 Sep 16. pii: 6701795. doi: 10.1093.
    PubMed    
    
    
    
54. 
    Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Sep 15. pii: 6701590. doi: 10.1093.
    PubMed    
    
    
    
55. KOVACS B, Mayinger M, Andratschke N, Saguner AM, et al
    Stereotactic arrhythmia radioablation: competitor or adjunct to catheter ablation?
    Eur Heart J. 2022;43:3279-3281.
    PubMed    
    
    
    August 2022
56. SMEDSRUD MK, Chivulescu M, Forsa MI, Castrini I, et al
    Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Aug 29. pii: 6676380. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. ECKARDT L, Sehner S, Suling A, Borof K, et al
    Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST - AFNET 4 trial.
    Eur Heart J. 2022 Aug 29. pii: 6675568. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. KONDO T, Abdul-Rahim AH, Talebi A, Abraham WT, et al
    Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
    Eur Heart J. 2022 Aug 26. pii: 6676501. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. ZEPPENFELD K, Tfelt-Hansen J, de Riva M, Winkel BG, et al
    2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
    Eur Heart J. 2022 Aug 26. pii: 6675633. doi: 10.1093.
    PubMed    
    
    
    
60. SAGRIS D, Shantsila E, Lip GYH
    Stroke risk stratification in patients with heart failure and sinus rhythm.
    Eur Heart J. 2022 Aug 26. pii: 6676507. doi: 10.1093.
    PubMed    
    
    
    
61. CHEN Q, Sen B, Feng X, Yang Q, et al
    Catastrophic atrial tachycardia-induced cardiomyopathy in a teenager treated by extracorporeal membrane oxygenation and stereotactic arrhythmia radioablation.
    Eur Heart J. 2022;43:3086.
    PubMed    
    
    
    
62. CORRADO D, Link MS, Schwartz PJ
    Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?
    Eur Heart J. 2022;43:3029-3040.
    PubMed     Abstract available
    
    
    
63. GRONDIN S, Davies B, Cadrin-Tourigny J, Steinberg C, et al
    Importance of genetic testing in unexplained cardiac arrest.
    Eur Heart J. 2022;43:3071-3081.
    PubMed     Abstract available
    
    
    
64. HUQI A, Zoccali C, Giugliano RP, De Caterina R, et al
    Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?
    Eur Heart J. 2022 Aug 19. pii: 6671685. doi: 10.1093.
    PubMed    
    
    
    
65. MARSTON NA, Garfinkel AC, Kamanu FK, Melloni GM, et al
    A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
    Eur Heart J. 2022 Aug 18. pii: 6671409. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. NARDUCCI ML, Volpe M
    Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation.
    Eur Heart J. 2022 Aug 8. pii: 6658237. doi: 10.1093.
    PubMed    
    
    
    
67. 
    Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Aug 5. pii: 6656112. doi: 10.1093.
    PubMed    
    
    
    
68. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
    PubMed    
    
    
    
69. SHIN J, Han K, Jung JH, Park HJ, et al
    Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2022 Aug 4. pii: 6646730. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2022
70. KHAIRY P
    Sudden cardiac death in adults with transposition of the great arteries and systemic right ventricles: preventing (night)MAREs.
    Eur Heart J. 2022;43:2695-2697.
    PubMed    
    
    
    
71. BRIDA M, Chessa M, Celermajer D, Li W, et al
    Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
    Eur Heart J. 2022;43:2660-2671.
    PubMed     Abstract available
    
    
    
72. 
    Corrigendum to: Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Jul 8. pii: 6633850. doi: 10.1093.
    PubMed    
    
    
    
73. LIP GYH, Lane DA, Lenarczyk R, Boriani G, et al
    Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2022;43:2442-2460.
    PubMed     Abstract available
    
    
    June 2022
74. PROTONOTARIOS A, Bariani R, Cappelletto C, Pavlou M, et al
    Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619317. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. JORDA P, Bosman LP, Gasperetti A, Mazzanti A, et al
    Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619318. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. GANDJBAKHCH E, Vischer AS
    Arrhythmogenic right ventricular cardiomyopathy: the never-ending quest for a risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619319. doi: 10.1093.
    PubMed    
    
    
    
77. GOYAL P, Kim M, Krishnan U, Mccullough SA, et al
    Post-operative atrial fibrillation and risk of heart failure hospitalization.
    Eur Heart J. 2022 Jun 28. pii: 6617280. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. MIDDELDORP ME, Albert CM
    Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery.
    Eur Heart J. 2022 Jun 28. pii: 6617281. doi: 10.1093.
    PubMed    
    
    
    
79. NINNI S, Longere B, Mirabel X
    Stereotactic radioablation to treat ventricular tachycardia related to a left ventricular mass.
    Eur Heart J. 2022;43:2341.
    PubMed    
    
    
    
80. 
    Erratum to: Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Jun 18. pii: 6610027. doi: 10.1093.
    PubMed    
    
    
    
81. WEI X, Zhou M, Chen Y, Chen M, et al
    Paroxysmal massive mitral regurgitation.
    Eur Heart J. 2022 Jun 17. pii: 6609956. doi: 10.1093.
    PubMed    
    
    
    
82. CREA F
    The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
    Eur Heart J. 2022;43:2165-2169.
    PubMed    
    
    
    
83. LADOUCEUR M, Van De Bruaene A, Kauling R, Budts W, et al
    A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle.
    Eur Heart J. 2022 Jun 8. pii: 6604048. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    PubMed    
    
    
    
85. BRIGNOLE M, Soranna D, Rienstra M
    Is APAF-CRT robust enough to change clinical practice?
    Eur Heart J. 2022;43:2161-2162.
    PubMed    
    
    
    
86. PABEL S, Sossalla S
    Atrial fibrillation and heart failure: novel insights into the chicken and egg dilemma.
    Eur Heart J. 2022 Jun 2. pii: 6599046. doi: 10.1093.
    PubMed    
    
    
    May 2022
87. JOHNSEN SP, Proietti M, Maggioni AP, Lip GYH, et al
    A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.
    Eur Heart J. 2022 May 22. pii: 6590386. doi: 10.1093.
    PubMed    
    
    
    
88. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    PubMed     Abstract available
    
    
    
89. REMME CA, Leclercq C, Behr ER
    The European Cardiac Arrhythmia Genetics (ECGen) Focus Group.
    Eur Heart J. 2022;43:1891-1894.
    PubMed    
    
    
    
90. LIUZZO G, Patrono C
    A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation.
    Eur Heart J. 2022 May 13. pii: 6585115. doi: 10.1093.
    PubMed    
    
    
    
91. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    PubMed    
    
    
    
92. CARRION-SANCHEZ I, Cobos-Gil MA
    Electrical alternans detected by an Apple Watch.
    Eur Heart J. 2022;43:1775.
    PubMed    
    
    
    April 2022
93. ODENING KE, van der Linde HJ, Ackerman MJ, Volders PGA, et al
    Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond.
    Eur Heart J. 2022 Apr 21. pii: 6571781. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. 
    Corrigendum to: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569859. doi: 10.1093.
    PubMed    
    
    
    
95. VAN DER MEER P, Rienstra M, van Veldhuisen DJ
    A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin?
    Eur Heart J. 2022 Apr 20. pii: 6571185. doi: 10.1093.
    PubMed    
    
    
    
96. CADRIN-TOURIGNY J, Bosman LP, Nozza A, Wang W, et al
    A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569858. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed     Abstract available
    
    
    
98. STIEGLIS R, Zijlstra JA, Riedijk F, Smeekes M, et al
    Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home.
    Eur Heart J. 2022;43:1465-1474.
    PubMed     Abstract available
    
    
    
99. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    PubMed    
    
    
    March 2022
100. SANDHU A, Varosy PD
     Left atrial appendage occlusion in patients unable to tolerate anticoagulation is cost-effective in Sweden: but how generalizable is this finding?
     Eur Heart J. 2022;43:1357-1359.
     PubMed    
     
     
     
101. SOLOMON SD, Claggett BL, Miao ZM, Diaz R, et al
     Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
     Eur Heart J. 2022 Mar 23. pii: 6552734. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. CREA F
     Novel mechanistic insights into ventricular arrhythmias and sudden death.
     Eur Heart J. 2022;43:1177-1180.
     PubMed    
     
     
     
103. CRIJNS HJGM, Sanders P, Albert CM, Lambiase PD, et al
     The year in cardiovascular medicine 2021: arrhythmias.
     Eur Heart J. 2022;43:1191-1197.
     PubMed    
     
     
     
104. CASTILHO BM, Domingues K, Damasio AF
     Pacemaker malcapture and wide QRS complexes.
     Eur Heart J. 2022;43:1272.
     PubMed    
     
     
     
105. SCHWARTZ PJ, Ackerman MJ
     Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
     Eur Heart J. 2022 Mar 18. pii: 6550339. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. SLATER NR, Murphy KR, Sikkel MB
     VT storm in long QT resulting from COVID-19 vaccine allergy treated with epinephrine.
     Eur Heart J. 2022;43:1176.
     PubMed    
     
     
     
107. MCINTYRE WF, Linz D
     Atrial fibrillation and stroke: who is low risk and what are we going to do about it?
     Eur Heart J. 2022 Mar 10. pii: 6546014. doi: 10.1093.
     PubMed    
     
     
     
108. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
     Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
     Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. PRINZEN FW, Auricchio A, Mullens W, Linde C, et al
     Electrical management of heart failure: from pathophysiology to treatment.
     Eur Heart J. 2022 Mar 10. pii: 6546052. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
     Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
     Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. MEHILLI J, Winhard M
     The CHADS-P2A2RC score: ready to guide the selection of treatment?
     Eur Heart J. 2022;43:1005-1007.
     PubMed    
     
     
     
112. NASSER R, Meyten N, Vermeersch P, Prihadi EA, et al
     When the solution becomes the problem: left atrial appendage occlusion device-related thrombus after 5 years.
     Eur Heart J. 2022;43:1015.
     PubMed    
     
     
     February 2022
113. KAUR H, McIntyre WF, Belley-Cote EP
     Ablate and pace for patients with atrial fibrillation: a fragile option?
     Eur Heart J. 2022 Feb 21. pii: 6533261. doi: 10.1093.
     PubMed    
     
     
     
114. JARED BUNCH T, Steinberg BA
     Clinical strokes in atrial fibrillation: the tip of the iceberg.
     Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
     PubMed    
     
     
     
115. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
     Silent brain infarcts impact on cognitive function in atrial fibrillation.
     Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. MUTAGAYWA RK, Chin A, Karaye K, Bonny A, et al
     Unmet needs in the management of arrhythmias among heart failure patients in Africa.
     Eur Heart J. 2022 Feb 15. pii: 6528559. doi: 10.1093.
     PubMed    
     
     
     
117. TAGGART P, Nash MP, Lambiase P
     Ventricular fibrillation: combined myocardial substrate and Purkinje ablation.
     Eur Heart J. 2022 Feb 9. pii: 6525334. doi: 10.1093.
     PubMed    
     
     
     
118. HAISSAGUERRE M, Cheniti G, Hocini M, Sacher F, et al
     Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation.
     Eur Heart J. 2022 Feb 3. pii: 6521660. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
119. CREA F
     Cardio-oncology: a focus on cardiovascular toxicities of cancer therapies and on atrial fibrillation in cancer.
     Eur Heart J. 2022;43:245-248.
     PubMed    
     
     
     
120. NARDUCCI ML, Volpe M
     Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
     Eur Heart J. 2022;43:261-262.
     PubMed    
     
     
     
121. NOUBIAP JJ
     The association of atrial fibrillation with mortality in patients with breast cancer.
     Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
     PubMed    
     
     
     
122. LAMBIASE PD, Theuns DA, Murgatroyd F, Barr C, et al
     Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.
     Eur Heart J. 2022 Jan 28. pii: 6516831. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. GUHA A, Alonso A, Addison D
     The association of atrial fibrillation with mortality in patients with breast cancer: author reply.
     Eur Heart J. 2022 Jan 28. pii: 6516863. doi: 10.1093.
     PubMed    
     
     
     
124. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
     Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
     Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
     PubMed     Abstract available
     
     
     
125. NICHOLLS M
     Preventing stroke in atrial fibrillation patients.
     Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
     PubMed    
     
     
     
126. 
     Corrigendum to: Incidence, Risk Factors and Mortality of Atrial Fibrillation in Breast Cancer: A SEER-Medicare Analysis.
     Eur Heart J. 2022 Jan 12. pii: 6505260. doi: 10.1093.
     PubMed    
     
     
     December 2021
127. 
     Erratum to: Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
     Eur Heart J. 2021 Dec 21. pii: 6472922. doi: 10.1093.
     PubMed    
     
     
     
128. NICHOLLS M
     Making connections to overcome arrhythmias.
     Eur Heart J. 2021;42:4878-4880.
     PubMed    
     
     
     
129. LABORI F, Persson J, Bonander C, Jood K, et al
     Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
     Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
     Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
     Eur Heart J. 2021 Dec 8. pii: 6456446. doi: 10.1093.
     PubMed    
     
     
     
131. CREA F
     Management of arrhythmias: the increasing role of artificial intelligence, genetics and cardiac resyncronization.
     Eur Heart J. 2021;42:4703-4706.
     PubMed    
     
     
     
132. ATTIA ZI, Harmon DM, Behr ER, Friedman PA, et al
     Application of artificial intelligence to the electrocardiogram.
     Eur Heart J. 2021;42:4717-4730.
     PubMed     Abstract available
     
     
     
133. HATALA R
     Rhythm control in asymptomatic 'early' atrial fibrillation: birth of a new paradigm?
     Eur Heart J. 2021 Dec 2. pii: 6448252. doi: 10.1093.
     PubMed    
     
     
     November 2021
134. BOR WL, Ten Berg JM
     Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
     Eur Heart J. 2021;42:4562-4564.
     PubMed    
     
     
     
135. AHLBERG G, Andreasen L, Ghouse J, Bertelsen L, et al
     Genome-wide association study identifies 18 novel loci associated with left atrial volume and function.
     Eur Heart J. 2021;42:4523-4534.
     PubMed     Abstract available
     
     
     
136. CERRONE M, Marron-Linares GM, van Opbergen CJM, Costa S, et al
     Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
     Eur Heart J. 2021 Nov 19. pii: 6431860. doi: 10.1093.
     PubMed     Abstract available
     
     
     
137. MERINO JL
     Atrial fibrillation and breast cancer: Casual or causal relationship?
     Eur Heart J. 2021 Nov 14. pii: 6427544. doi: 10.1093.
     PubMed    
     
     
     
138. GUHA A, Fradley MG, Dent SF, Weintraub NL, et al
     Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.
     Eur Heart J. 2021 Nov 14. pii: 6427396. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2021
139. HEIDBUCHEL H, Van Gelder IC, Desteghe L
     ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project.
     Eur Heart J. 2021 Oct 25. pii: 6409895. doi: 10.1093.
     PubMed    
     
     
     
140. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
     Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
     Eur Heart J. 2021 Oct 16. pii: 6398359. doi: 10.1093.
     PubMed    
     
     
     
141. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
     Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
     Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
     PubMed     Abstract available
     
     
     
142. NAGARAJAN VD, Lee SL, Robertus JL, Nienaber CA, et al
     Artificial intelligence in the diagnosis and management of arrhythmias.
     Eur Heart J. 2021;42:3904-3916.
     PubMed     Abstract available
     
     
     
143. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
     Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
     Eur Heart J. 2021;42:3932-3944.
     PubMed     Abstract available
     
     
     
144. CREA F
     The growing role of artificial intelligence and of wearable devices in the management of arrhythmias.
     Eur Heart J. 2021;42:3889-3893.
     PubMed    
     
     
     
145. GARG L, Fradley MG
     QT prolongation and cancer therapeutics: a coming Tempest or Much Ado About Nothing?
     Eur Heart J. 2021;42:3929-3931.
     PubMed    
     
     
     
146. VAN DER WERF C, Lambiase PD
     Initiation and management of polymorphic ventricular tachycardia: history gone full circle.
     Eur Heart J. 2021;42:3976-3978.
     PubMed    
     
     
     
147. ROSSO R, Hochstadt A, Viskin D, Chorin E, et al
     Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis.
     Eur Heart J. 2021;42:3965-3975.
     PubMed     Abstract available
     
     
     
148. LINDE C
     Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial.
     Eur Heart J. 2021 Oct 6. pii: 6382271. doi: 10.1093.
     PubMed    
     
     
     September 2021
149. RUSSO AM
     Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
     Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
     PubMed    
     
     
     
150. WALSH R, Adler A, Amin AS, Abiusi E, et al
     Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
     Eur Heart J. 2021 Sep 24. pii: 6374783. doi: 10.1093.
     PubMed     Abstract available
     
     
     
151. TINKER A
     Does knowledge of the mutation in hereditary long QT syndrome aid risk stratification?
     Eur Heart J. 2021 Sep 20. pii: 6372801. doi: 10.1093.
     PubMed    
     
     
     
152. CREA F
     The ESC Guidelines on cardiac pacing and resynchronization, and the many facets of atrial fibrillation.
     Eur Heart J. 2021;42:3411-3414.
     PubMed    
     
     
     
153. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
     Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrill
     Eur Heart J. 2021 Sep 14. pii: 6370283. doi: 10.1093.
     PubMed    
     
     
     
154. GLIKSON M, Nielsen JC, Kronborg MB, Michowitz Y, et al
     2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
     Eur Heart J. 2021;42:3427-3520.
     PubMed    
     
     
     
155. LIN YN, Mesquita T, Sanchez L, Chen YH, et al
     Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice.
     Eur Heart J. 2021;42:3558-3571.
     PubMed     Abstract available
     
     
     
156. SCHWARTZ PJ, Tan HL
     Long QT syndrome, artificial intelligence, and common sense.
     Eur Heart J. 2021 Sep 11. pii: 6368899. doi: 10.1093.
     PubMed    
     
     
     
157. SCHWARTZ PJ, Moreno C, Kotta MC, Pedrazzini M, et al
     Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.
     Eur Heart J. 2021 Sep 10. pii: 6368299. doi: 10.1093.
     PubMed     Abstract available
     
     
     
158. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
     Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
     Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
     PubMed     Abstract available
     
     
     
159. STEINBERG C, Krahn AD
     Quinidine vs. ICD therapy in short-coupled ventricular fibrillation-is a randomized trial the next logical step?
     Eur Heart J. 2021 Sep 4. pii: 6364089. doi: 10.1093.
     PubMed    
     
     
     
160. BELHASSEN B
     Quinidine vs. ICD in patients with short-coupled idiopathic ventricular fibrillation: a call for a multicenter randomized trial.
     Eur Heart J. 2021 Sep 4. pii: 6364083. doi: 10.1093.
     PubMed    
     
     
     
161. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
     Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
     Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
     PubMed     Abstract available
     
     
     
162. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
     Day-to-day measurement of physical activity and risk of atrial fibrillation.
     Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
     PubMed     Abstract available
     
     
     
163. PRIFTI E, Fall A, Davogustto G, Pulini A, et al
     Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome.
     Eur Heart J. 2021 Sep 1. pii: 6361017. doi: 10.1093.
     PubMed     Abstract available
     
     
     
164. ELLIOTT AD, Middeldorp ME, Linz DK
     The ins and outs of physical activity monitoring: implications for atrial fibrillation management.
     Eur Heart J. 2021 Sep 1. pii: 6361015. doi: 10.1093.
     PubMed    
     
     
     August 2021
165. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
     AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
     Eur Heart J. 2021 Aug 28. pii: 6358077. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. CURTAIN JP, Docherty KF, Jhund PS, Petrie MC, et al
     Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
     Eur Heart J. 2021 Aug 27. pii: 6358075. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
     Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
     Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. LIGHT PE
     Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure.
     Eur Heart J. 2021 Aug 27. pii: 6358226. doi: 10.1093.
     PubMed    
     
     
     
169. CHIANG PH, Hsu YC, Wei JC
     Methodological considerations when discussing the fracture risk of atrial fibrillation patients taking different drug.
     Eur Heart J. 2021 Aug 11. pii: 6348063. doi: 10.1093.
     PubMed    
     
     
     
170. HUANG HK, Tu YK, Loh CH
     Fracture risk associated with different oral anticoagulants in patients with atrial fibrillation: updated evidence from real-world observational studies and clinical trials.
     Eur Heart J. 2021 Aug 11. pii: 6348060. doi: 10.1093.
     PubMed    
     
     
     
171. WANG N, Sun Y, Zhang H, Wang B, et al
     Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.
     Eur Heart J. 2021 Aug 10. pii: 6347324. doi: 10.1093.
     PubMed     Abstract available
     
     
     
172. SALEM JE, Nguyen LS, Moslehi JJ, Ederhy S, et al
     Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
     Eur Heart J. 2021 Aug 9. pii: 6346756. doi: 10.1093.
     PubMed     Abstract available
     
     
     
173. NICHOLLS M
     Reflections on EHRA 2021.
     Eur Heart J. 2021;42:2880-2881.
     PubMed    
     
     
     
174. RASMUSSEN PV, Hylek E
     Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants.
     Eur Heart J. 2021 Aug 4. pii: 6339772. doi: 10.1093.
     PubMed    
     
     
     
175. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
     Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
     Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
     PubMed     Abstract available
     
     
     
176. REIFFEL JA
     When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
     Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
     PubMed    
     
     
     July 2021
177. WILDE AAM, Wu CI
     Does function trump bioinformatics in Brugada syndrome-associated SCN5A mutation calling? Patients, computers, and patches.
     Eur Heart J. 2021;42:2864-2865.
     PubMed    
     
     
     
178. ISHIKAWA T, Kimoto H, Mishima H, Yamagata K, et al
     Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
     Eur Heart J. 2021;42:2854-2863.
     PubMed     Abstract available
     
     
     
179. ALHUMAID W, Yogasundaram H, Senaratne JM
     Slow bidirectional ventricular tachycardia as a manifestation of immune checkpoint inhibitor myocarditis.
     Eur Heart J. 2021;42:2868.
     PubMed    
     
     
     
180. GUASCH E, Nattel S
     Ageing, comorbidities, and the complex determinants of atrial fibrillation in athletes.
     Eur Heart J. 2021 Jul 23. pii: 6327053. doi: 10.1093.
     PubMed    
     
     
     
181. ADABAG S, Madjid M, Cheng A
     An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic.
     Eur Heart J. 2021 Jul 19. pii: 6323687. doi: 10.1093.
     PubMed    
     
     
     
182. 
     Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.
     Eur Heart J. 2021 Jul 16. pii: 6322394. doi: 10.1093.
     PubMed    
     
     
     
183. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
     Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
     Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. BUNTING KV, Stanbury M, Tica O, Kotecha D, et al
     Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial.
     Eur Heart J. 2021;42:2411-2414.
     PubMed    
     
     
     June 2021
185. 
     Erratum to: Alcohol Consumption, Cardiac Biomarkers and Risk of Atrial Fibrillation and Adverse Outcomes.
     Eur Heart J. 2021 Jun 30. pii: 6311430. doi: 10.1093.
     PubMed    
     
     
     
186. VAN DER REE MH, Postema PG
     What's in a name? further classification of patients with apparent idiopathic ventricular fibrillation.
     Eur Heart J. 2021 Jun 21. pii: 6306957. doi: 10.1093.
     PubMed    
     
     
     
187. SCHNABEL RB, Fabritz L, Kirchhof P
     Mobile health for walking on the tightrope of optimal physical activity to reduce the risk of atrial fibrillation.
     Eur Heart J. 2021 Jun 20. pii: 6306826. doi: 10.1093.
     PubMed    
     
     
     
188. 
     Corrigendum to: A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
     Eur Heart J. 2021 Jun 16. pii: 6300115. doi: 10.1093.
     PubMed    
     
     
     
189. VERSTRAELEN TE, van Lint FHM, Bosman LP, de Brouwer R, et al
     Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
     Eur Heart J. 2021 Jun 11. pii: 6296140. doi: 10.1093.
     PubMed     Abstract available
     
     
     
190. LEE SR, Choi EK, Jung JH, Han KD, et al
     Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
     Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2021
191. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
     Accelerometer-derived physical activity and risk of atrial fibrillation.
     Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. PARK S, Lee S, Kim Y, Lee Y, et al
     Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
     Eur Heart J. 2021 May 23. pii: 6282432. doi: 10.1093.
     PubMed     Abstract available
     
     
     
193. BENN M
     Atrial Fibrillation And Chronic Kidney Disease.
     Eur Heart J. 2021 May 23. pii: 6282434. doi: 10.1093.
     PubMed    
     
     
     
194. TOMSITS P, Clauss S, Kaab S
     Genetic insight into sick sinus syndrome. Is there a pill for it or how far are we on the translational road to personalized medicine?
     Eur Heart J. 2021;42:1972-1975.
     PubMed    
     
     
     
195. MARSTON NA, Han L, Olivotto I, Day SM, et al
     Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
     Eur Heart J. 2021;42:1988-1996.
     PubMed     Abstract available
     
     
     
196. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
     Genetic insight into sick sinus syndrome.
     Eur Heart J. 2021;42:1959-1971.
     PubMed     Abstract available
     
     
     
197. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
     Genetic insight into sick sinus syndrome.
     Eur Heart J. 2021;42:1959-1971.
     PubMed     Abstract available
     
     
     
198. STEINBERG C, Davies B, Mellor G, Tadros R, et al
     Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
     Eur Heart J. 2021 May 19. pii: 6278425. doi: 10.1093.
     PubMed     Abstract available
     
     
     
199. CSENGERI D, Sprunker NA, Schnabel RB
     Alcohol and atrial fibrillation: dose matters, not so much the type.
     Eur Heart J. 2021 May 9. pii: 6272848. doi: 10.1093.
     PubMed    
     
     
     
200. MESSERLI FH, Dobner S
     Alcohol and atrial fibrillation: not all drinks are created equal.
     Eur Heart J. 2021 May 8. pii: 6272093. doi: 10.1093.
     PubMed    
     
     
     
201. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
     What do we learn by repeating the ABC?
     Eur Heart J. 2021;42:1707-1709.
     PubMed    
     
     
     
202. GNECCHI M, Sala L, Schwartz PJ
     Precision Medicine and cardiac channelopathies: when dreams meet reality.
     Eur Heart J. 2021;42:1661-1675.
     PubMed     Abstract available
     
     
     
203. DELISE P
     Risk stratification in Brugada syndrome: the challenge of the grey zone.
     Eur Heart J. 2021;42:1696-1697.
     PubMed    
     
     
     
204. PROBST V, Goronflot T, Anys S, Tixier R, et al
     Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome.
     Eur Heart J. 2021;42:1687-1695.
     PubMed     Abstract available
     
     
     
205. MINOIS D, Sellal JM, Magnin I, de Chillou C, et al
     Left ventricular diverticulum associated with two concealed atrioventricular accessory pathways.
     Eur Heart J. 2021;42:1714.
     PubMed    
     
     
     April 2021
206. GALIUTO L, Volpe M
     Cryoblation as first-line treatment of new-onset atrial fibrillation?
     Eur Heart J. 2021;42:1543-1544.
     PubMed    
     
     
     
207. SMOLDEREN KG, Burg MM
     A broken heart after child loss.
     Eur Heart J. 2021;42:1496-1498.
     PubMed    
     
     
     
208. BRIEGER D, Freedman B
     Decoding stroke risk scores in atrial fibrillation: still more work to do.
     Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
     PubMed    
     
     
     March 2021
209. EL-BATTRAWY I, Lang S, Zhou X, Akin I, et al
     Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
     Eur Heart J. 2021;42:1270-1272.
     PubMed    
     
     
     
210. PAPPONE C, Ciconte G, Micaglio E, Monasky MM, et al
     Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
     Eur Heart J. 2021;42:1273-1274.
     PubMed    
     
     
     
211. YOUNIS A, Goldenberg I
     Extending the MADIT-ICD benefit score to heterogenous heart failure populations.
     Eur Heart J. 2021 Mar 18. pii: 6177051. doi: 10.1093.
     PubMed    
     
     
     
212. POSTEMA PG, Walsh R, Bezzina CR
     Illuminating the path from genetics to clinical outcome in Brugada syndrome.
     Eur Heart J. 2021;42:1091-1093.
     PubMed    
     
     
     
213. BEHR ER, Ben-Haim Y, Ackerman MJ, Krahn AD, et al
     Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
     Eur Heart J. 2021;42:1073-1081.
     PubMed     Abstract available
     
     
     
214. CICONTE G, Monasky MM, Santinelli V, Micaglio E, et al
     Brugada syndrome genetics is associated with phenotype severity.
     Eur Heart J. 2021;42:1082-1090.
     PubMed     Abstract available
     
     
     
215. IRIART X, Metras A, Coiffic A, Thambo JB, et al
     Late device-related thrombus after left atrial appendage closure: never let your guard down.
     Eur Heart J. 2021;42:1050.
     PubMed    
     
     
     February 2021
216. SAWANO S, Nakayama A, Morita H, Komuro I, et al
     Rathke's cleft cyst induced cardiac arrest.
     Eur Heart J. 2021;42:714.
     PubMed    
     
     
     
217. CRIJNS HJGM, Prinzen F, Lambiase PD, Sanders P, et al
     The year in cardiovascular medicine 2020: arrhythmias.
     Eur Heart J. 2021;42:499-507.
     PubMed     Abstract available
     
     
     
218. SCHNEEWEIS C, Ahrens I, Saygili E, Steven D, et al
     Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation.
     Eur Heart J. 2021;42:544.
     PubMed    
     
     
     January 2021
219. KITE TA, Gershlick AH
     High-risk NSTE-ACS: high time for robust data.
     Eur Heart J. 2021;42:352.
     PubMed    
     
     
     
220. HAMILTON GW, Lim HS
     Ventricular tachycardia vs. supraventricular tachycardia with aberrancy.
     Eur Heart J. 2021;42:133.
     PubMed    
     
     
     December 2020
221. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
     Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
     Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
     PubMed     Abstract available
     
     
     
222. WILDE AAM, Lodder EM
     Biomarkers in inherited arrhythmias: necessity for validation and collaboration.
     Eur Heart J. 2020;41:4523-4524.
     PubMed    
     
     
     
223. HAMILTON RM, Chatterjee D, Saguner AM
     Biomarkers in inherited arrhythmias: opportunities for validation and collaboration.
     Eur Heart J. 2020;41:4521-4522.
     PubMed    
     
     
     November 2020
224. VERHAMME P, Budts W, Van de Werf F
     Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?
     Eur Heart J. 2020;41:4178-4180.
     PubMed    
     
     
     April 2020
225. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
     Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
     Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2020
226. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
     Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
     Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2019
227. LANCINI D, Shetty R
     Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
     Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
     PubMed    
     
     
     
228. KALLA M, Hao G, Tapoulal N, Tomek J, et al
     The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
     Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2019
229. PACKER M
     What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
     Eur Heart J. 2019 Aug 7. pii: 5544750. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2019
230. REDDY YNV, Borlaug BA, O'Connor CM, Gersh BJ, et al
     Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.
     Eur Heart J. 2019 Jun 14. pii: 5519089. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: